AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

INVION LTD

0.080

-0.003-3.61%

Volume:1.00

Turnover:0.08

Market Cap:6.20M

PE:-0.76

High:0.080

Open:0.080

Low:0.080

Close:0.083

Loading ...

Overview Company News Filings

Invion Doses First Patient in Non Melanoma Skin Cancer Drug Study

MT Newswires Live

Invion Terminates Share Purchase Agreement with Lind

MT Newswires Live

BUZZ-Australia's Invion drops to 1-week low on termination of share purchase agreement

Invion raises $2M in share placement to support cancer research work

The Market Herald

Invion Ltd-Proposed Issue of Securities - Ivx

THOMSON REUTERS

BRIEF-Invion Ltd Seeks Trading Halt

Invion Ltd - Seeks Trading Halt Pending Announcement on Capital Raising

THOMSON REUTERS

BRIEF-Invion Expands Agreement With Hanlim To Include Oesophageal Cancer

Invion Ltd - Expanded Collaboration & Funding Agreement With Major South Korean Pharmaceutical Group Hanlim to Include Oesophageal Cance

THOMSON REUTERS

Weekly wrap: shares take a breather as Wall Street finds caution

3 ASX Penny Stocks With Market Caps Over A$20M To Watch

Simply Wall St.

BUZZ-Australia's Invion jumps most in 3 yrs as skin cancer treatment trial begins

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IVX.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IVX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVX.AU\",,,,,undefined,":{"symbol":"IVX.AU","market":"AU","secType":"STK","nameCN":"INVION LTD","latestPrice":0.08,"timestamp":1747980720000,"preClose":0.083,"halted":0,"volume":1,"delay":0,"nameEN":"INVION LTD","floatShares":48948056,"shares":77478388,"eps":-0.105328,"marketStatus":"Not Yet Opened","change":-0.003,"latestTime":"05-23 16:12:00 AEST","open":0.08,"high":0.08,"low":0.08,"amount":0.08,"amplitude":0,"askPrice":0.088,"askSize":18000,"bidPrice":0.08,"bidSize":28714,"shortable":3,"etf":0,"ttmEps":-0.105328,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1748217600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.083,"openAndCloseTimeList":[[1747958400000,1747980000000]],"volumeRatio":0.000012655344377545056,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVX.AU\",,,,,undefined,":{"symbol":"IVX.AU","floatShares":48948056,"roa":"-26.39%","roe":"-43.80%","lyrEps":-0.087599,"volumeRatio":0.000012655344377545056,"shares":77478388,"dividePrice":0,"high":0.08,"amplitude":0,"preClose":0.083,"low":0.08,"week52Low":0.079,"pbRate":"0.47","psRate":"4.23","week52High":0.5,"institutionHeld":0,"latestPrice":0.08,"committee":0.229353,"eps":-0.105328,"divideRate":0,"volume":1,"delay":0,"ttmEps":-0.105328,"open":0.08,"prevYearClose":0.28,"prevWeekClose":0.095,"prevMonthClose":0.1,"prevQuarterClose":0.1,"fiveDayClose":0.095,"twentyDayClose":0.1,"sixtyDayClose":0.14},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IVX.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533182321","title":"Invion Doses First Patient in Non Melanoma Skin Cancer Drug Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2533182321","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533182321?lang=en_us&edition=fundamental","pubTime":"2025-05-05 08:10","pubTimestamp":1746403832,"startTime":"0","endTime":"0","summary":"Invion  said the first patient was administered a dose of its topical formulation of its drug candidate, INV043, formulation of its lead drug candidate, INV043 in an open label  Phase  I/II  trial for non melanoma skin cancer , according to a Friday filing with the Australian bourse.The open-label trial evaluates the safety and efficacy of INV043 for photodynamic cancer therapy, the filing said.A safety review committee will assess whether to adjust the dose-light interval or expand the trial, the filing added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7509","BK7508","BK7096","IVX.AU"],"gpt_icon":0},{"id":"2517542499","title":"Invion Terminates Share Purchase Agreement with Lind","url":"https://stock-news.laohu8.com/highlight/detail?id=2517542499","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517542499?lang=en_us&edition=fundamental","pubTime":"2025-03-05 13:00","pubTimestamp":1741150845,"startTime":"0","endTime":"0","summary":"Invion  issued a termination notice for the share purchase agreement with Lind Global Fund II dated June 27, 2024, and will be repaying the latest tranche installment to Lind, according to a Wednesday Australian bourse filing.The Agreement is a staged private placement in monthly installments of AU$100,000 per month, which may be raised up to AU$500,000 per month, over a 12-month period from June 2024, the filing added.The company said it will also repay the latest installment of AU$250,000 provided by Lind at a 5% premium.The deal termination carries no cost for the life-science firm, per the filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IVX.AU","BK7508","BK7509","BK7096"],"gpt_icon":0},{"id":"2517958069","title":"BUZZ-Australia's Invion drops to 1-week low on termination of share purchase agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2517958069","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517958069?lang=en_us&edition=fundamental","pubTime":"2025-03-05 10:57","pubTimestamp":1741143476,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Invion drops to 1-week low on termination of share purchase agreement** Shares of Invion IVX.AX fall 3.7% to A$0.130, their lowest levels since February 25** The life sciences co issues a termination notice for the share purchase agreement with Lind Global Fund, dated June 27, 2024** The agreement is a private placement of A$100,000  every month over 12 months from June 2024** Co to repay the latest instalment to Lind Global** Invion stock on track for a third consecutive day of losses** Stock down 53.6% YTD, including current session's moves     ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3N3PO0DD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","IVX.AU","BK7509","BK7508"],"gpt_icon":0},{"id":"2516642665","title":"Invion raises $2M in share placement to support cancer research work","url":"https://stock-news.laohu8.com/highlight/detail?id=2516642665","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516642665?lang=en_us&edition=fundamental","pubTime":"2025-03-04 11:46","pubTimestamp":1741059960,"startTime":"0","endTime":"0","summary":"Biotech company Invion Ltd  is raising $2 million in a two-tranche share placement to support a series of clinical trials and development activities for its Photosoft technology, seeking to treat a range of cancers.The company said it had completed the placement, with shares priced at 14 cents each – a 2.5% premium to the 30-day volume-weighted average price. This was chiefly managed by Blue Ocean Equities and has already attracted strong demand – reflected in the fact the initial goal was $1.5 million.The funds will go towards recruiting from a second site for the company’s Phase I/II skin cancer trial, and commencement of a Phase I/II anogenital trial in collaboration with the Peter MacCallum Cancer Centre in Melbourne.Crucially, a successful outcome in the latter could enable orphan drug designation in the U.S. to fast-track trials in the rare disease indications.The material provided in this article is for information only and should not be treated as investment advice. Viewers are","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/invion-raises-2m-in-share-placement-to-support-cancer-research-work-2025-03-04/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7509","IVX.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"2516494660","title":"Invion Ltd-Proposed Issue of Securities - Ivx","url":"https://stock-news.laohu8.com/highlight/detail?id=2516494660","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516494660?lang=en_us&edition=fundamental","pubTime":"2025-03-04 07:49","pubTimestamp":1741045786,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUE9SJQN5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7509","BK7508","IVX.AU"],"gpt_icon":0},{"id":"2514438356","title":"BRIEF-Invion Ltd Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2514438356","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514438356?lang=en_us&edition=fundamental","pubTime":"2025-02-28 06:15","pubTimestamp":1740694559,"startTime":"0","endTime":"0","summary":"BRIEF-Invion Ltd Seeks Trading HaltFeb 28 (Reuters) - Invion Ltd IVX.AX:SEEKS TRADING HALT PENDING ANNOUNCEMENT ON CAPITAL RAISINGFurther company coverage: IVX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PI2E8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","IVX.AU","BK7096","BK7509"],"gpt_icon":0},{"id":"2514356488","title":"Invion Ltd -  Seeks Trading Halt Pending Announcement on Capital Raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2514356488","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514356488?lang=en_us&edition=fundamental","pubTime":"2025-02-28 06:15","pubTimestamp":1740694529,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PI2E8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7509","BK7508","IVX.AU","BK7096"],"gpt_icon":0},{"id":"2514302440","title":"BRIEF-Invion Expands Agreement With Hanlim To Include Oesophageal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2514302440","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514302440?lang=en_us&edition=fundamental","pubTime":"2025-02-26 09:16","pubTimestamp":1740532572,"startTime":"0","endTime":"0","summary":"BRIEF-Invion Expands Agreement With Hanlim To Include Oesophageal CancerFeb 26  - Invion Ltd IVX.AX:EXPANDED COLLABORATION & FUNDING AGREEMENT WITH MAJOR SOUTH KOREAN PHARMACEUTICAL GROUP HANLIM TO INCLUDE OESOPHAGEAL CANCERFurther company coverage: IVX.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PG10Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7509","BK7508","IVX.AU","BK7096"],"gpt_icon":0},{"id":"2514047682","title":"Invion Ltd -  Expanded Collaboration & Funding Agreement With Major South Korean Pharmaceutical Group Hanlim to Include Oesophageal Cance","url":"https://stock-news.laohu8.com/highlight/detail?id=2514047682","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514047682?lang=en_us&edition=fundamental","pubTime":"2025-02-26 06:05","pubTimestamp":1740521133,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG10Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IVX.AU","BK7508","BK7509","BK7096"],"gpt_icon":0},{"id":"2489029866","title":"Weekly wrap: shares take a breather as Wall Street finds caution","url":"https://stock-news.laohu8.com/highlight/detail?id=2489029866","media":"Small Caps","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489029866?lang=en_us&edition=fundamental","pubTime":"2024-12-07 07:09","pubTimestamp":1733526545,"startTime":"0","endTime":"0","summary":"Australia’s share market took a breather on Friday as Wall Street turned cautious about whether the Federal Reserve will continue to cut interest rates this month.By the close of trade the ASX 200 had dropped 0.6% or 54 points to 8420.9 points with only one of the 11 sectors closing up.The fall meant that the ASX 200 has lost 0.2% for the week after reaching a record high of 8514.5 points on Tuesday.The utilities index was up almost 0.4%, driven higher by a 1.4% share price rise to $7.27 for Australia’s biggest natural gas pipeline company APA Group , which jumped after the energy regulator confirmed it would not subject the company’s South West Queensland Gas Pipeline to full price regulation.An underperform rating attributed to Domino’s Pizza  by Macquarie cut the share price by 2.3% to $32.48, with the broker saying that a decline in franchisee profitability was jeopardising the chain’s new store openings.","market":"us","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2024/12/Dec-2024-ASX.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2024/12/Dec-2024-ASX.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/weekly-wrap-shares-take-breather-wall-street-finds-caution/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["BK7137","GBZ.AU","ATA.AU","BK7135","BK7129","LU7.AU","BK7509","APA.AU","BK7142","BK7078","WBC.AU","GRR.AU","XAO.AU","NVQ.AU","XKO.AU","BK7016","GRR","BK7511","IVX.AU","DMP.AU","CBA.AU","BK7104","BK7508","STO.AU","NAB.AU","PDT","WDS.AU","BK7507","BK7148","ALL.AU","29M.AU","XJO.AU","BK7011","BK7095","BK7096","ILU.AU","ANZ.AU","BK7061","ARN.AU"],"gpt_icon":0},{"id":"2488903930","title":"3 ASX Penny Stocks With Market Caps Over A$20M To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2488903930","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488903930?lang=en_us&edition=fundamental","pubTime":"2024-12-04 07:08","pubTimestamp":1733267327,"startTime":"0","endTime":"0","summary":"The Australian sharemarket is poised for a slight retreat, with ASX 200 futures indicating a 0.28% drop following mixed signals from global markets and geopolitical tensions. Amidst these fluctuations, investors often seek opportunities in diverse areas such as penny stocks—an investment category that, despite its historical connotations, remains relevant today. These stocks typically represent smaller or newer companies and can offer compelling growth potential when backed by solid financials.ASX:IVX Financial Position Analysis as at Dec 2024. Overview: Latin Resources Limited is a mining company focused on exploring and developing projects in Australia, Peru, Argentina, and Brazil with a market capitalization of A$476.24 million.Operations: The company's revenue is derived from the exploration and evaluation of mining projects, amounting to A$0.09 million.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-asx-penny-stocks-market-230847233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["HLO.AU","EZZ.AU","BK7088","WEB.AU","BK7096","EVO.AU","BK7062","BK7070","BK7132","BK7508","BK7095","XKO.AU","NGI.AU","BK7077","SRV.AU","BK7048","BK7509","BK7504","SHA.AU","MXI.AU","IVX.AU","LRS.AU","LBL.AU","XAO.AU","BK7055","XJO.AU","VLS.AU","BK7133","ANG.AU","BK7164"],"gpt_icon":0},{"id":"2488933495","title":"BUZZ-Australia's Invion jumps most in 3 yrs as skin cancer treatment trial begins","url":"https://stock-news.laohu8.com/highlight/detail?id=2488933495","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488933495?lang=en_us&edition=fundamental","pubTime":"2024-12-03 08:41","pubTimestamp":1733186489,"startTime":"0","endTime":"0","summary":"** Shares of Invion    rise as much as 130.6% to A$0.415, posting their biggest intraday percentage gain since Oct. 28, 2021   ** Stock hits its highest level since July 16   ** Cancer treatment developer says the first patient has been dosed in the early-stage trial of its light absorbing material \"INV043\", aimed to treat non-melanoma skin cancer   ** About 483,000 shares change hands, compared with the 30-day average volume of around 37,000   ** Stock trims YTD losses to 30%, including session's move ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XKO.AU","BK7508","BK7096","XJO.AU","XAO.AU","BK7509","IVX.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IVX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-11-20","symbol":"IVX.AU","defaultRemindTime":1732057200000,"type":"split","dateTimestamp":1732021200000,"forFactor":100,"toFactor":1,"ratio":100}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IVX.AU\",market:\"AU\",,,undefined,":[]}}